A simple idea, a revolutionary application
Immunotherapy rests on a simple idea: activate the patient's own immune system to recognize and attack cancer cells. The practical implementation took decades of research.
Main types
- Checkpoint inhibitors (such as pembrolizumab).
- CAR-T cell therapy: engineering the patient's T cells.
- Cancer vaccines: still under development.
- Targeted antibodies.
Striking results
In some cancers like advanced melanoma and lung cancer, immunotherapy delivered surprising survival rates and even complete remission in some patients. But it is no magic bullet: only 20–40% of patients respond, and the challenge remains identifying responders in advance.
We no longer just fight cancer — we teach the body how to fight it.
د
About the author
د. نجيدة
محاضر متخصص في المجال الطبي، يقدم محتوى تعليمياً عالي الجودة.
